Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1, GSTT1, NAT1 and NAT2

Pharmacogenetics

Volumn 11, Issue 5, 2001, Pages 389-398

  Godschalk, R W L ^a   Dallinga, J W ^a   Wikman, H ^a   Risch, A ^a   Kleinjans, J C S ^a   Bartsch, H ^a   Van Schooten, F J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

4 ABP; DNA adducts; Glutathione S transferase; N acetyltransferase

Indexed keywords

4 BIPHENYLAMINE; ACYLTRANSFERASE; DNA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; HEMOGLOBIN; PROTEIN NAT1; PROTEIN NAT2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ADDUCT; DRUG ACETYLATION; ENVIRONMENTAL EXPOSURE; ENZYME METABOLISM; FEMALE; GAS CHROMATOGRAPHY; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; NORMAL HUMAN; POLLUTANT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; ARYLAMINE N-ACETYLTRANSFERASE; DNA ADDUCTS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEINS; SMOKING;

EID: 0034959436     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200107000-00003     Document Type: Article

References (43)

1. The role of individual susceptibility in cancer burden related to environmental exposure
2. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer
3. Isolation of lymphocytes, granulocytes and macrophages
4. Correlation between trans-stilbene oxide glutathione conjugation activity and the deletion mutation in the glutathione-S-transferase class Mu gene detected by polymerase chain reaction
5. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1)
6. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers
7. Modulation of DNA adduct levels in human white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphisms
8. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure
9. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: Studies on the interactions with GSTM1 in lung, oral, gastric and colorectal cancers
10. Genetic metabolic polymorphisms and the risk of cancer; a review of the literature
11. Determination of human NAT2 acetylator genotype by restriction fragment length polymorphism and allele-specific amplification
12. Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers
13. Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationships to micronuclei levels and the glutathione S-transferase M1 genotype
14. 32P-adduct assay; comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures
15. The glutathione supergene family: Regulation of GST and the contribution of the Isoenzymes to cancer chemoprevention and drug resistance
16. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
17. Relationship between hprt mutant frequency, aromatic-DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers
18. Aromatic-DNA adducts, micronuclei and genetic polymorphisms for CYP1A1 and GST1 in chimney sweeps
19. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo
20. The human glutathione S-transferase supergene family, its polymorphism and its effects on susceptibility to lung cancer
21. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics and whites: Application to metabolic epidemiology
22. 4-aminobiphenyl-DNA adducts and p53 mutations in bladder cancer
23. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions
24. White blood cell DNA adducts, smoking and NAT2 and GSTM1 genotypes in bladder cancer: A case-control study
25. Human glutathione S-transferase theta (GSTT1): cDNA and the characterization of a genetic polymorphism
26. N-acetyltransferase 2 phenotype but not NAT1* 10 genotype affects aminobiphenyl-hemoglobin adduct levels
27. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI-GSTM1* 0/* 0 genotypes
28. The impact of glutathione-S-transferase M1 and cytochrome P450 1A1 genotypes on white blood cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans
29. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 Msp1 and GSTM1 genotypes in lung patients
30. Inherited factors and environmental exposures in cancer risk
31. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes
32. Aromatic DNA adducts as predictor of lung cancer risk in a nested case-control study
33. The role of N-acetylation polymorphisms at NAT1 and NAT2 in smoking-associated bladder cancer
34. Acetylation phenotype, carcinogen-haemoglobin adducts and cigarette smoking
35. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens
36. DNA adducts as marker of exposure to carcinogens and risk of cancer
37. Polymorphisms in GSTP1, GSTM1 and GSTT1 and susceptibility to colorectal cancer
38. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility
39. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels and bladder cancer risk in white, black, and Asian men in Los Angeles, California
40. Glutathione S-transferase genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and non-smokers